Ability Inc., through its subsidiaries, provides interception, geolocation, and cyber intelligence products and solutions for security and intelligence agencies, military forces, law enforcement agencies, and homeland security agencies worldwide. It specializes in off-air interception of voice, SMS, and data communication from cellular and satellite communication networks; and deciphering solutions for cellular and satellite communications. The company offers strategic and tactical cellular interception systems for intercepting mobile phone traffic and tracking mobile phone users; and satellite link interception systems, as well as international mobile subscriber identity catchers, advanced CDMA interception systems, in-between interception systems, and ultimate interceptions. It also provides geolocation systems to geographically target mobile phones; cyber solutions that enable the user to extract and view information from mobile phones. Ability Inc. was founded in 1994 and is headquartered in Tel Aviv, Israel....
+See More2023-03-14 16:43:00 Tuesday ET
Several feasible near-term reforms can substantially narrow the scope for global tax avoidance by closing information loopholes. Thomas Pogge and Krishen
2023-11-30 08:29:00 Thursday ET
In addition to the OECD bank-credit-card model and Chinese online payment platforms, the open-payments gateways of UPI in India and Pix in Brazil have adapt
2018-07-09 09:39:00 Monday ET
The Federal Reserve raises the interest rate again in mid-2018 in response to 2% inflation and wage growth. The current neutral interest rate hike neither b
2025-01-31 09:26:00 Friday ET
The current homeland industrial policy stance worldwide seeks to embed the new notion of global resilience into economic statecraft. In the broader cont
2020-05-21 11:30:00 Thursday ET
Most blue-ocean strategists shift fundamental focus from current competitors to alternative non-customers with new market space. W. Chan Kim and Renee Ma
2018-05-07 07:32:00 Monday ET
President Trump seeks to honor his campaign promise of lower U.S. medical costs by forcing higher big-pharma prices in foreign countries such as Canada, Bri